Role of circulating tumor DNA in metastatic appendiceal neoplasms: A systematic review

Medicine and Dentistry

• Systematic Review 100%
• Circulating Tumor DNA 100%
• Appendix Tumor 100%
• Neoplasm 17%
• Metastatic Carcinoma 11%
• Malignant Neoplasm 5%
• DNA Fragment 5%
• Overall Survival 5%
• Cancer 5%
• Progression Free Survival 5%
• Oncology 5%
• Primary Tumor 5%
• Disease Course 5%
• Hyperthermic Intraperitoneal Chemotherapy 5%
• Tumor 5%
• Peritoneal Disease 5%

Keyphrases

• Circulating Tumor DNA (ctDNA) 100%
• Appendiceal Neoplasms 100%
• Detection Rate 11%
• Metastatic Disease 11%
• Cancer Patients 5%
• DNA Fragments 5%
• Clinical Practice 5%
• Poor Differentiation 5%
• Overall Survival 5%
• Blood Samples 5%
• KRAS mutation 5%
• Tumor Specimens 5%
• Screening Diagnosis 5%
• Oncology 5%
• Progression-free Survival 5%
• Tumor Grade 5%
• PubMed 5%
• Well-differentiated 5%
• Disease Course 5%
• Primary Malignancy 5%
• Non-invasive Device 5%
• DNA Detection 5%
• Positive Rate 5%
• Cochrane 5%
• Tumor DNA 5%
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 5%
• DNA Assay 5%
• Poorly Differentiated Tumor 5%
• Peritoneal Disease 5%
• PRISMA Guidelines 5%
• Appendiceal Tumor 5%
• Moderately Differentiated 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Circulating Tumor DNA 100%
• Appendix Tumor 100%
• Neoplasm 17%
• Malignant Neoplasm 11%
• Progression Free Survival 5%
• Overall Survival 5%
• Disease Course 5%
• DNA Fragment 5%
• Primary Tumor 5%
• Intraperitoneal Chemotherapy 5%